Nov 24, 2020
Medication interactions can pose a significant health risk. Identifying and understanding the degree of interaction and appropriate management allows for optimization of care while minimizing risk. In this interview, Glenn A. Hirsch, Barbara Wiggins, and Henry D. Huang discuss drug-drug interactions of concern in...
Nov 17, 2020
What is the optimal therapeutic strategy in non-ST-segment elevation acute coronary syndromes (NSTE-ACS) in patients not pretreated with P2Y12 adenosine diphosphate receptor antagonists, and why reduce the time to invasive strategy in NSTE-ACS? In this interview, John Gorcsan, Laurent Bonello, and Arjun Majithia discuss...
Nov 10, 2020
Clinicians must understand the appropriate role of catheter ablation in clinical practice. In this episode, A. John Camm moderates a debate between Douglas L. Packer and Peter R. Kowey about whether ablation is still the salvation in the post-CABANA era.
Nov 3, 2020
The coronavirus disease 2019 (COVID-19) pandemic has profoundly changed health care delivery worldwide. In this interview, Joseph Marine, Ty Gluckman, and Yuvraj Chowdhury discuss “Case Rates, Treatment Approaches, and Outcomes in Acute Myocardial Infarction During the Coronavirus Disease 2019 Pandemic.” This study...